Advanced Search
Contact | Corporate | Help

Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Sponsors:
  • University of California, San Diego
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Rheumatoid Arthritis
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: rituximab
Enrollment:
24

Additional information about NCT00147966.


SourceSolution © 2008-2012